<?xml version="1.0" encoding="UTF-8"?>
<p id="para140">Antivirals like these are usually simple to manufacture, and can be taken in pill form, both of which are big advantages. But 99 per cent of potential small-molecule drugs fail, says Ball. So developing new antivirals from scratch could take years.</p>
